Trend
DailyDowntrend (confirmed)
4 hourExpanding
1 hourAscending Triangle
15 minExpanding
5 minExpanding
Daily trend turns up above $15.12
Key levels
Resistance$5.02
Resistance$4.59
Support$4.22
Support$3.85
Latest news & SEC filings
No headlines in the last 90 days.
Cingulate is a biopharmaceutical company that develops medicines for ADHD and anxiety using its own timed-release drug delivery technology. Its pipeline includes two stimulant-based ADHD candidates, one containing dexmethylphenidate and the other dextroamphetamine, aimed at children, teenagers, and adults, along with a buspirone-based anxiety treatment. The company is based in the United States and intends to sell its products there through commercialization partners.
Based on the company's 10-K filed Mar 18, 2026.
Nasdaq · Healthcare
SEPT Low Target
$17.00
SEPT Mid Target
$20.00
SEPT High Target
$23.00
Analyst Consensus
$20.00
Thesis
Trained on trillions of real market data to read price action and give you a simple, emotionless trading strategy for CING.
Start Free Trial →Valuation Verdict
UNDERVALUED
Methods Used
P/B, PEG, Analyst Consensus
Fair Value
$14.53
5
Moat Score
NONE
1/9
Piotroski Score
-15.3
Altman Z-Score
Insider Signal
BUYING
9 buys / 0 sells (90d)
Congress Signal
NEUTRAL
0 buys / 0 sells (90d)
Institutional
N/A
Short Squeeze Risk
LOW
Signal: NEUTRAL
| Name | Title | Type | Shares | Value | Date |
|---|---|---|---|---|---|
| Hargroves Thomas Jeffrey | director | Buy | 97,276 | $490K | Feb 13, 2026 |
Insider trades, congress trades, institutional flows, and short interest — updated daily with real-time alerts.
See All Smart Money Signals →Revenue YoY
N/A%
3yr Revenue CAGR
N/A%
EPS Growth YoY
59.12%
FCF Growth YoY
6.7%
Revenue Trend
UNKNOWN
SEPT Investing tracks real-time dark pool institutional trades for CING, including block trade sizes, dollar values, and buy/sell side classification. Dark pool trades reveal where institutional investors are positioning before moves become visible on public exchanges.
| Time | Price | Size | Value | Side |
|---|---|---|---|---|
| 14:32:37 | $4.51 | 3,768 | $$17K | SELL |
| 14:30:33 | $4.59 | 1,000 | $$5K | SELL |
| 24:03:05 | $4.42 | 11,985 | $$53K | SELL |
| 20:26:55 | $4.61 | 4,176 | $$19K | BUY |
| 18:23:13 | $4.53 | 1,500 | $$7K | BUY |
5 dark pool trades shown · $$101K preview volume
Real-time institutional flow, block trades, and net positioning
SEPT's Trading AI has generated a free, downloadable PDF research report for Cingulate Inc. (CING) covering valuation analysis, financial health assessment, growth projections, smart money tracking, earnings and key price levels. For research only, not investment advice.
Report includes: PDF download, detailed valuation models (DCF, P/E, EV/EBITDA), institutional flow analysis, congress and insider trade tracking, FinBERT news sentiment (1 articles analyzed), and SEC filing intelligence...
Trained on trillions of real market data to read price action and give you a simple, emotionless trading strategy. SEPT tells you when to buy, when to sell, and grades every stock so you never trade blind.
Try SEPT Free for 7 Days →Cingulate Inc. (CING) is at $4.51, down 2.69% (-$0.13) at the Nov 12, 2026 close.
The average analyst price target for CING is $20.00, ranging from $20 to $20, based on 1 analysts.
Analyst ratings for CING: 0 Buy, 3 Hold, 0 Sell — consensus Hold.
CING last reported on Aug 13, 2026: EPS -$0.45 vs -$0.63 expected — a beat of 28.0%.
CING does not currently pay a dividend.
Support: $4.22, $3.85, $3.16. Resistance: $4.59, $5.02, $5.36.
Insider activity: BUYING, 9 buys and 0 sells in the last 90 days.